Tuesday, November 12, 2024
Sunnybrook Inventors: Dr. Juan Carlos Zúñiga-Pflücker
Dr. Juan Carlos Zúñiga-Pflücker, senior scientist in the Odette Cancer Research Program and co-founder of SRI spin-off company Notch Therapeutics, is developing innovative therapies from asking fundamental questions.
Thursday, October 17, 2024
SRI spin-off company, Conavi Medical, completes reverse takeover to become public
The combined company will focus on continuing to commercialize and develop Conavi’s Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.
Monday, October 7, 2024
SRI spin-off company, Arrayus, announces Health Canada approval of its focused ultrasound therapy system
Arrayus Technologies Inc., a SRI spin-off company, is pleased to announce that its MRI-guided FUS system has been granted approval by Health Canada for the ablation of uterine fibroid tissue.
Monday, September 9, 2024
Sunnybrook Inventors: Dr. Hon Leong
Dr. Hon Leong emphasizes the importance of translating research into clinical practice. Using ideas from his lab, Dr. Leong’s company, Yex, is advancing research in regenerative medicine, antibody production, clinical diagnostics, and drug discovery.
Wednesday, August 7, 2024
Stryker completes acquisition of SRI spin-off company MOLLI Surgical
Stryker, a global leader in medical technologies, has announced that it has completed the acquisition of MOLLI Surgical Inc., a SRI spin-off company specializing in the development of wire-free soft tissue localization technology for breast conserving surgery.
